Skip to content
Screener

Glaukos GKOS Interest And Other Expense Net

Discontinued — last reported Q4 '24

Segments

By segment

See full
Development And Commercialization Of Ophthalmic Therapies-$1.27M+31.4%

Other financials

Income statement

See full
Revenue$185.6M+49.5%
Gross profit$151.6M+55.9%
Operating income-$17.3M+23.9%
Net income-$18.4M+6.5%
EPS (diluted)-$0.31+8.8%

Balance sheet

See full
Cash & equivalents$114.5M+13.6%
Total debt$105.9M-1.4%
Total equity$682.5M-10.8%
Total assets$920.5M-6.7%

Cash flow

See full
Operating cash flow$14.8M
CapEx$2.7M+132%
Free cash flow-$16.5M+19.4%

Valuation

See full
Market cap$10.08B+98.7%
Enterprise value$10.07B+98.2%
P/S16.5×+4.7×

Profitability

See full
Gross margin61%-15.4pp
Operating margin-31.6%+22.2pp
Net margin-30.7%+23.3pp
FCF margin-13.2%-3.9pp

Returns & leverage

See full
Return on equity-26%-11,301pp
Debt / equity0.2×0.0×
Current ratio-0.5×

Where this comes from

Reported directly by Glaukos in its filing.

Tagged under the XBRL concept gkos:InterestAndOtherExpenseNet.

The source filing: Glaukos’s 10-K, filed February 25, 2025.

Filed
Feb 25, 2025
Fiscal year
FY2024
Accession
0001558370-25-001402
Line itemYear ended / December 31, 2024Year ended / December 31, 2023Year ended / December 31, 2022
Interest income11,1059,1642,375
Interest expense(10,040)(13,633)(13,720)
Charges associated with convertible senior notes(18,012)--
Other expense, net(6,288)(558)(4,771)
Total non-operating expense(23,235)(5,027)(16,116)
Loss before taxes(145,601)(133,727)(98,429)
Income tax provision771934766
Net loss$(146,372)$(134,661)$(99,195)

ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

FAQ

What is Glaukos's interest and other expense net?
Glaukos (GKOS) reported interest and other expense net of $1.57M in Q4 2024.
How has Glaukos's interest and other expense net changed year-over-year?
Glaukos's interest and other expense net increased by 1026.9% year-over-year, from $139.5K to $1.57M.
What is the long-term trend for Glaukos's interest and other expense net?
Over 3 years (2021 to 2024), Glaukos's interest and other expense net has grown at a 13.4% compound annual growth rate (CAGR), from $4.31M to $6.29M.

Ask your AI about Glaukos's interest and other expense net.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude